Concepedia

Christina M. Arieta

CM

Statistics

Publications

5

Citations

508

H-Index

5

Active since

2019

Affiliations

BioNTech (United States)(Current)

BioNTech (Germany)

Christina M. Arieta is an author at BioNTech (United States) specializing in immunology, life sciences, and major histocompatibility complex.

Publications per year

2019–2025

5

Publications

5

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

Jennifer G. Abelin, Dewi Harjanto, Matthew Malloy et al. · Immunity · 2019 · 264 citations · Full text

, , +14

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

Asaf Poran, Dewi Harjanto, Matthew Malloy et al. · Genome Medicine · 2020 · 101 citations · Full text

, , +17

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg et al. · Cell · 2023 · 89 citations · Full text

, , +17

Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial

Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler et al. · Nature Medicine · 2025 · 40 citations · Full text

, , +16

Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction

Jennifer G. Abelin, Dewi Harjanto, Matthew Malloy et al. · Immunity · 2021 · 14 citations · Full text

, , +14

1–5 of 5